Jeannette Potts, MD

Jeannette Potts, MD
Glickman Urological Institute, Cleveland Clinic, Cleveland, OH

Richard E. Payne, MD
Clinical Instructor, Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA; Private Practice, North Coast Family Medical Group, Encinitas, CA

Correspondence: Jeannette Potts, MD, Glickman Urological Institute, Cleveland Clinic, 9500 Euclid Avenue, A100, Cleveland, OH 44195; pottsj@ccf.org

Dr. Potts reported that she has no financial relationships that pose a potential conflict of interest with this article.

Dr. Payne reported that he has received honoraria, consulting fees, and an educational grant from Eli Lilly/ICOS for teaching/speaking, consulting, and contracted research; honoraria and consulting fees from Sanofi-Aventis for teaching/speaking and advisory board membership; consulting fees from Boehringer Ingelheim for teaching/speaking and consulting; consulting fees from Pfizer, Johnson & Johnson, and Thomson Healthcare for consulting; and consulting fees from Reliant Pharmaceuticals for serving on an advisory committee. He also reported having an ownership interest in and receiving consulting fees from MedVantx.

Jeannette Potts, MD
Glickman Urological Institute, Cleveland Clinic, Cleveland, OH

Richard E. Payne, MD
Clinical Instructor, Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA; Private Practice, North Coast Family Medical Group, Encinitas, CA

Correspondence: Jeannette Potts, MD, Glickman Urological Institute, Cleveland Clinic, 9500 Euclid Avenue, A100, Cleveland, OH 44195; pottsj@ccf.org

Dr. Potts reported that she has no financial relationships that pose a potential conflict of interest with this article.

Dr. Payne reported that he has received honoraria, consulting fees, and an educational grant from Eli Lilly/ICOS for teaching/speaking, consulting, and contracted research; honoraria and consulting fees from Sanofi-Aventis for teaching/speaking and advisory board membership; consulting fees from Boehringer Ingelheim for teaching/speaking and consulting; consulting fees from Pfizer, Johnson & Johnson, and Thomson Healthcare for consulting; and consulting fees from Reliant Pharmaceuticals for serving on an advisory committee. He also reported having an ownership interest in and receiving consulting fees from MedVantx.

Jeannette Potts, MD
Glickman Urological Institute, Cleveland Clinic, Cleveland, OH

Richard E. Payne, MD
Clinical Instructor, Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA; Private Practice, North Coast Family Medical Group, Encinitas, CA

Correspondence: Jeannette Potts, MD, Glickman Urological Institute, Cleveland Clinic, 9500 Euclid Avenue, A100, Cleveland, OH 44195; pottsj@ccf.org

Dr. Potts reported that she has no financial relationships that pose a potential conflict of interest with this article.

Dr. Payne reported that he has received honoraria, consulting fees, and an educational grant from Eli Lilly/ICOS for teaching/speaking, consulting, and contracted research; honoraria and consulting fees from Sanofi-Aventis for teaching/speaking and advisory board membership; consulting fees from Boehringer Ingelheim for teaching/speaking and consulting; consulting fees from Pfizer, Johnson & Johnson, and Thomson Healthcare for consulting; and consulting fees from Reliant Pharmaceuticals for serving on an advisory committee. He also reported having an ownership interest in and receiving consulting fees from MedVantx.